Next, ovarian cancer (A2780 and ES-2) cells were subjected to increasing doses of MLN4924 treatment and it was found that MLN4924 >20 μM inhibited the expression of CFP1. This evidence concerns the gene CXXC1 and ovarian carcinoma.